MarginsXMarginsX
Home › Markets › NVACW

Profusa, Inc. (NVACW)

NVACW is quoted over the counter, not listed on an exchange. Profusa, Inc. files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.

Close
No daily closes stored yet
No new price since Oct 28, 2025: the price source has sent no bar for 138 sessions
1-year return
No daily closes stored yet
Market cap
The company also trades on Nasdaq as PFSA; this OTC line is another class or a foreign line, so its cap is not computed
P/E and P/S
Needs a market cap · Needs a market cap
On trailing twelve months to June 30, 2026 (10-Q)

Profile

FieldValue
TickerNVACW, quoted over the counter
SEC CIK0001859807
SEC industry codeSurgical & Medical Instruments & Apparatus
Business addressNew York, NY
Incorporated inDE

Warning signs

Cash runway
0.4 months
$719K cash at June 30, 2026
Share count, 1 year
+64781.2%
2025-11-18 to 2026-11-13 · +690811.4% over 3 years
Going-concern doubt
Yes
10-Q filed November 13, 2026
Insider net buying, 12 months
-$116K
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"As of September 30, 2026, there continue to be factors which raise substantial doubt about the Company's ability to continue as a going concern within one year from the date the condensed consolidated financial statements are issued."
10-Q 2026-11-13
Cash and burn$719K cash; operating cash flow -$5.1M a quarter.Report 2026-06-30
Shares outstanding5,681,947 (2026-11-13); 65,680,958 a year earlier; 6,167,882 three years earlier. 1y figure adjusted for splits (1-for-7500 overall); 3y figure adjusted for splits (1-for-7500 overall).Cover page 2026-11-13
Reverse splits, 3 years3; latest 1-for-4 on 2026-08-17Source 2026-08-17
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 months3 (8-K item 3.01)8-K 2026-08-31
Delisting25-NSE filed25-NSE 2025-05-22
AuditorCBIZ CPAs P.C., San Francisco, California, United States; changed auditors 2 times in 24 months8-K 4.01 2026-10-09
Late filings, 12 months2 NT noticesNT 10-Q 2026-08-14
Insider trades, 12 monthsBought $37K, sold $153K on the open marketSEC Forms 3/4/5 data sets 2026-09-30
Market cap checkThe listing's market cap implies 605,647 shares at the 2026-11-13 price; the latest SEC cover count is 5,681,947 as of 2026-11-13. One of the two share counts is stale.Nasdaq screener and SEC cover page

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
Not filed-$8.8M-$2.6M$719K$17.0MNeeds four quarters10-Q 2026-08-19
Q1 2026
2026-03-31
Not filed-$3.5M-$2.6M$375K$16.6MNeeds four quarters10-Q 2026-08-19
Q4 2025
2025-12-31
Not filed-$8.6M-$5.1M$1.8M$10.8MNeeds four quarters10-K 2026-04-15
Q3 2025
2025-09-30
Not filed-$22.2M-$10.0M$3.0M$19.7MNeeds four quarters10-Q 2025-11-19
Q2 2025
2025-06-30
Not filed-$2.3M-$589K$39K$1.9MNeeds four quarters10-Q 2026-08-19
Q1 2025
2025-03-31
Not filed-$2.7M-$537K$19K$3.4MNeeds four quarters10-Q 2026-08-19
Q4 2024
2024-12-31
$0-$2.3M-$238K$191K$48.8M$100K10-K 2026-04-15
Q3 2024
2024-09-30
$75K-$2.5M-$1.2M$533$3.4MNeeds four quarters10-Q 2025-11-19

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B32026-07-07
Latest annual report10-K2026-04-15
Latest quarterly / interim10-Q2026-11-13
Latest current report8-K2026-11-06
Latest proxyPRE 14A2026-11-10

Source: SEC EDGAR submissions feed, 326 recent filings. All filings on EDGAR.

The full dossier has every filing, quarterly and annual financials, the health record and a price chart.

Open the full dossier